Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-10-21
2009-11-17
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S333000
Reexamination Certificate
active
07618974
ABSTRACT:
The present invention relates to compounds that inhibit bacterial gyrase and/or Topo IV and pharmaceutically acceptable compositions comprising said compounds. These compounds, and compositions thereof, are useful in treating bacterial infection. Accordingly, the present invention also relates to methods for treating bacterial infections in mammals.
REFERENCES:
patent: 4174400 (1979-11-01), Mrozik
patent: 4512998 (1985-04-01), Nafissi-Varchei
patent: 5529998 (1996-06-01), Habich et al.
patent: 5643935 (1997-07-01), Dykstra et al.
patent: 6632809 (2003-10-01), Grillot et al.
patent: 2004/0043989 (2004-03-01), Grillot et al.
patent: 2005/0038247 (2005-02-01), Charifson et al.
patent: 2006/0025424 (2006-02-01), Charifson et al.
patent: 0 433 648 (1991-06-01), None
patent: 0738726 (1996-10-01), None
patent: 1 055 668 (2000-11-01), None
patent: 99/35155 (1999-07-01), None
patent: 00/49015 (2000-08-01), None
patent: 00/71522 (2000-11-01), None
patent: 02/060879 (2002-08-01), None
patent: WO 02/060879 (2002-08-01), None
patent: 03/105846 (2003-12-01), None
patent: WO 03/105846 (2003-12-01), None
patent: 2005/012292 (2005-02-01), None
patent: WO 2005/012292 (2005-02-01), None
patent: 2007056330 (2007-05-01), None
Skopenko, V.V., et al., “Organotin Carbamoyldicyanomethanide, nitrosocarbamoylcyanomethanide, and carbamoylcyanides,” retrieved from STN Database accession No. 101:230674, XP002254350 abstract and Dopovidi Akademii Nauk Ukrains'Koi RSR, Seriya B: Geologichni, Khimichni Ta Biologichni Nauki, 7:44-46 (1984).
Hubschwerlen et al., “Pyrimido[1,6-a]benzimidazoles: A New Class of DNA Gyrase Inhibitors” J. Med. Chem, vol. 35, No. 8, pp. 1385-1392, 1992.
Sun et al., “Synthesis and Evaluation of Terbenzimidazoles as Topoisomerase I Inhibitors” J. Med. Chem., vol. 38, No. 18, pp. 3638-3644, 1995.
Kus et al., “Synthesis and Antimicrobial Activities of 5-fluoro-1,2,6-trisubstituted Benzimidazole Carboxamide and Acetamide Derivatives” Arch. Pharm. Pharm. Med. Chem., vol. 334, No. 11, pp. 361-365, 2001.
Singh S.K. et al., “Studies in antiparasitic agents: Part 13- Synthesis of 4-aryl-2 substitutedamino-thiazoles as potential anthelminitics,” Indian J. Chem., 28B (9): 786-789 (1989).
Nicolaus B.J.R., “Symbiotic Approach to Drug Design,” Decision Making in Drug Research, pp. 173-186 (1983).
Charifson Paul
Deininger David
Drumm Joseph
Grillot Anne-Laure
LeTiran Arnaud
Badia Michael C.
Desai Rita J
O'Dell David K
Vertex Pharmaceuticals Incorporated
LandOfFree
Gyrase inhibitors and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gyrase inhibitors and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gyrase inhibitors and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4116208